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Abstract 
Scope: This study investigated the mechanistic details by which gamma-tocotri-
enol (γ-T3) manipulates adipocyte differentiation in human adipose derived stem 
cells (hASCs). 
Methods and results: γ-T3 specifically inhibited the early stage of adipocyte differ-
entiation by acting on downstream of C/EBP-β but upstream of C/EBP-α in hASCs. 
In searching a potential mechanism, we identified that γ-T3 promoted two cata-
bolic signaling pathways: (i) AMP kinase (AMPK), and (ii) enhanced autophagy, as 
assessed by autophagic flux and cytosolic autophagosome (LC3II) accumulation. 
In addition, chronic exposure of γ-T3 induced caspase3-mediated apoptotic cell 
death. The blockage of AMPK by a dominant negative mutant of AMPK was in-
sufficient to normalize γ-T3-mediated autophagy, suggesting that enhanced au-
tophagic activity of γ-T3 is independent of AMPK activation. Intriguingly, AMPK 
inhibition significantly restored PPAR-γ activation, but marginally rescued lipid-
loaded adipocyte morphology due to, at least partly, a lack of lipid droplet-coat-
ing protein. These data suggest that γ-T3 activates AMPK and autophagy signal-
ing, which synergistically contributes to the suppression of adipogenic conversion 
of hASCs into adipocytes. 
Conclusion: These results provide a novel insight into the molecular mechanism in-
volved in anti-adipogenic action of γ-T3 in humans via AMPK and autophagy ac-
tivation. Thus, γ-T3may constitute a new dietary avenue to attenuate hyperplas-
tic obesity in humans. 
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Abbreviations: Ad, adenovirus; AMPK, AMP kinase; C/EBP, CCAAT/enhancer-bind-
ing proteins; CQ, chloroquine; DN, dominant negative; γ-T3, gamma-tocotrienol; 
GFP, green florescent protein; hASCs, human adipose derived stem cells; mTOR, 
mammalian targets of rapamycin; PPAR-γ, peroxisome proliferator activated re-
ceptor gamma; PLIN, perilipin; T3s, tocotrienols; TPs, tocopherols  
1 Introduction 
Vitamin E is a generic descriptor that includes derivatives of tocopherols 
(TPs) and tocotrienols (T3s). Due to an unsaturated isoprenoid side chain, 
T3s are smaller, more hydrophobic, and thus more proficient for penetration 
into cell membrane than TPs. T3s are further categorized into alpha, beta, 
gamma, and delta isoforms depending on the substitution pattern of methyl 
groups on the chromanol ring. Among these isomers, gamma-tocotrienol 
(γ-T3) displays multiple bioactivities including lowering cholesterol synthe-
sis and cardiovascular risk [1–3], attenuating hepatic TG accumulation [4–
6], improving insulin sensitivity [7, 8], and reducing the risk of cancer [9–12] 
in cells, animal models, and some human studies. These immune-modula-
tory and antiproliferative characteristics of γ-T3 are attributed to its ability 
to modify pathological conditions by targeting multiple pathways (review 
in [13]), including NFκB [14, 15], Wnt [16], mammalian targets of rapamy-
cin (mTOR) [11, 17], and autophagy [9, 18, 19]. Despite a large body of evi-
dence that γ-T3 is an extraordinary signaling modifier in various cell types, 
only limited information is available as to whether γ-T3 modifies the signal-
ing pathways in adipocytes. 
More than 16 percent of children and adolescents are obese in the United 
States, and the prevalence has more than tripled over the past three de-
cades [20, 21]. One of the prominent pathophysiological features of child-
hood obesity is adipogenesis, an increase in the number of fat cells resulting 
from the conversion of mesenchymal stem cells into new adipocytes (also 
known to adipocyte hyperplasia). Prevention of childhood obesity is criti-
cal, as the abnormal hyperplasia in childhood predisposes to a higher risk 
of metabolic complications in adulthood including type 2 diabetes and car-
diovascular diseases [22]. Adipogenesis is under the control of a cascade of 
transcription factors including CCAAT/enhancer binding proteins (C/EBPs) 
and peroxisome proliferator activated receptor gamma (PPAR-γ); it is well 
established that terminal adipocyte differentiation is driven by the master 
transcription factor PPAR-γ. However, the molecular dynamics of early-phase 
adipogenesis remains to be unraveled. Studies in cultured cells and in ani-
mals have shown that a disturbance of signaling pathways frequently mod-
ified in cancer could also affect adipogenesis. For example, inhibition of his-
tone deacetylase activity [23], activation of wingless signaling [24], limited 
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nutrient availability or energy homeostasis [25], and interruption of autoph-
agy [26, 27] have all been negatively correlated with white fat cell formation. 
In support of this concept, several phytochemicals, which are not PPAR-γ an-
tagonists per se, have been shown to exert anti-adipogenic activity by tar-
geting the aforementioned signaling pathways [28–30]. Moreover, inhibition 
of adipogenesis is often accompanied by apoptosis [31, 32], suggesting that 
early-phase adipogenesis is also the critical step for determining cell fate. 
Much mechanistic information on adipogenesis is derived from 3T3L1 pre-
adipocytes, a well-established murine hybridoma cell line. Previously, Uto-
Kondo et al. reported that γ-T3 inhibits the conversion of 3T3L1 preadipo-
cytes into adipocytes via modification of Akt signaling [33]. Our rationale 
for using human adipose derived stem cells (hASCs) was based on the fol-
lowing reasons: (i) 3T3L1 preadipocytes are mouse hybridoma cells, thus it 
is difficult to distinguish anti-adipogenic effects from antitumor effects; (ii) 
3T3L1 preadipocytes are committed preadipocytes that have already lost 
their stem cells properties; and (iii) 3T3L1 preadipocytes undergo postcon-
fluent mitogenic expansion, which is not found in primary adipogenic pre-
cursor cells [34]. Therefore, investigation of anti-adipogenic mechanism of 
γ-T3 in the unmodified human adipocyte precursor cells would be impor-
tant to attain physiological significance. Here, we report that γ-T3 is a po-
tent negative regulator of adipogenesis in hASCs by manipulating catabolic 
signaling pathways including AMP kinase (AMPK)/mTOR and the autoph-
agy/apoptosis axis, which have not been reported previously in 3T3L1 cells. 
2 Materials and methods 
2.1 Chemicals reagents 
All cell culture wares were purchased from Fisher Scientific. Fetal bovine se-
rum and penicillin-streptomycin were purchased from Cellgro Mediatech, 
Inc. (Herndon, VA, USA). Rosiglitazone (BRL49653) was purchased from Cay-
man Chemical. All other chemicals and reagents were purchased from Sigma 
Chemical Co (St. Louis, MO, USA), unless otherwise stated. 
2.2 Preparation of hASCs and adipogenic differentiation 
Abdominal adipose tissue was obtained from females with a body mass 
index of ~30 during liposuction or abdominal plastic surgeries. All pro-
tocols and procedures were approved by the Institutional Review Board 
(#693–2011) at the University of Florida. Isolation of hASCs and differentia-
tion of into adipocytes were conducted as Skurk et al. described previously 
[35]. Briefly, tissue was minced and enzymatically digested for 45 min in a 
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Krebs-Ringer buffer containing 1 mg/mL collagenase (CLS-1; Worthington) 
and 2% BSA. The digested tissue was then filtered through 100 μm mesh 
and pelleted by centrifuging at 600 × g for 5 min. The collected hASCs were 
resuspended in red blood cell lysis buffer (Biolegend) for 10 min and centri-
fuged to remove most of the contaminating erythrocytes. Cultures of hASCs 
were grown in proliferation medium containing DMEM/Ham’s F12, 10% fe-
tal bovine serum, 15 mM HEPES (pH 7.4), 50 U/mL penicillin and 50 μg/mL 
streptomycin. For induction to adipogenic differentiation, cells were seeded 
(5 × 105/cm2) in 6-well dishes and allowed to attach for 24 h in prolifera-
tion medium. After attachment, cultures were grown for the next 3 days in 
differentiation medium containing 0.25 mM isobutylmethylxanthine, 1 μM 
rosiglitazone, and 500 nM human insulin in commercially available human 
adipocyte medium (AM-1, ZenBio). Adipocyte medium (AM-1) was replen-
ished every 3 days. Under these conditions, approximately 50–80% of the 
cells differentiated into adipocytes by 10–12 days post differentiation. Each 
independent experiment was repeated at least twice using a mixture of cells 
from three or four subjects to avoid individual variation. 
2.3 Preparation of T3s and TP 
Isomers of α-, β-, and γ-T3s with a purity of 70, 60, and 90%, respectively, 
were kindly provided by Carotech Inc. (Edison, NJ). α-TP was purchased 
from Sigma. Five millimolar of T3s (α-, β-, and γ-T3) and TP were prepared 
in DMSO as Ahn et al. described previously [14]. Small aliquots of T3s and 
TP stock were kept at −20 °C and freshly diluted to 0.1–10 mM at the time 
of addition to hASCs. 
2.4 Cell viability assay 
The cytotoxic effect of T3s was determined using the XTT cell viability kit 
(Cell Signaling Technology) according to the manufacturer’s protocol. Briefly, 
undifferentiated and fully differentiated hASCs were cultured in 96-well 
plates with a seeding density of ~20 000 cells/well. Cells were incubated 
with either DMSO or increasing concentrations of T3 isomers for 24 h (Fig. 
1). Medium was then replaced with fresh medium containing XTT solution 
for 3 h at 37°C before measurement of OD 450 nm using a Synergy H1 hy-
brid plate reader (BioTek). 
2.5 qPCR and microarray analysis 
Gene-specific primers for real-time quantitative PCR (qPCR) were obtained 
from Integrated DNA Technologies (Chicago, IL,USA). Total RNA was iso-
lated with Trizol reagent (Invitrogen). To remove the potential genomic DNA 
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contamination, mRNA was treated with DNase (Mediatech), and 2 μg of 
mRNA was converted into cDNA in a total volume of 20 μL (iScript cDNA 
synthesis kit, Bio-Rad). Gene expression was determined by real-time qPCR 
(CFX96, Bio-Rad), and relative gene expression was normalized by the aver-
age of two reference genes, 36B4 and GAPDH (primer sequences are avail-
able in Supporting Information Table 1). 
2.6 Western blot analysis 
To prepare total cell lysates, monolayers of hASC cultures were scraped with 
ice-cold radioimmune precipitation assay buffer (Thermo Scientific) with 
protease inhibitors (Sigma) and phosphatase inhibitors (2 mM Na3VO4, 20 
mM β-glycerophosphate, and 10 mM NaF). Proteins were fractionated us-
ing 8 or 10% SDS-PAGE, transferred to PVDF membranes, and incubated 
with the relevant antibodies. Chemiluminescence from ECL (Western Light-
ning) solution was detected with FluorChem E (Cell Biosciences). For the 
detection of LC3 I and II bands, 15% SDSPAGE was used and the proteins 
were transferred to a PVDF membrane with a semidry transfer unit (Hoefer 
TE77X). Polyclonal or rabbit monoclonal antibodies targeting phospho-Akt 
(Ser473, #4060), total Akt (#9279), phospho-extracellular signal-related ki-
nase (ERK) (#4370), total-ERK (#4695), phospho-mTOR (#5536), total mTOR 
(#2983), phospho-p70S6 kinase (#9280), total p70S6 kinase (#2708), phos-
pho-AMPK (#2535), total-AMPK (#2630), cleaved PARP (#5625), cleaved cas-
pase-3 (#9664), PPAR-γ (#2443), FAS (#3180), β-actin (#4967), LC3 (#9562), 
p62 (#8025), beclin-1 (#3738), and IκBα (#4812) were purchased from Cell 
Signaling Technology. The mouse monoclonal antibodies for aP2 were pur-
chased from Santa Cruz Biotechnology. 
2.7 Adenoviral delivery of dominant negative AMPK and LC3-GFP 
Adenovirus (Ad) harboring null AMPK α mutation (dominant negative, Ad 
AMPK-DN) was a generous gift from Dr. Jae Bum Kim at Seoul National Uni-
versity. Green florescent protein (GFP)-tagged Ad LC3 was a gift from Jae-
Sung Kim at the University of Florida [36, 37]. Ad AMPK-DN, Ad LC3-GFP, 
and Ad GFP were amplified as previously described by Lee et al. [38]. The ti-
tration of recombinant Ad was performed using a commercial titration kit 
(Adeno-XTM Rapid Titer kit, Clonetech). To determine the autophagy acti-
vation, either Ad GFP or Ad LC3-GFP were infected (MOI 5) in hASCs be-
fore adipogenic differentiation (Fig. 5). To determine whether inhibition of 
AMPK activity rescues hASCs from γ-T3-mediated suppression of adipo-
genesis, Ad-AMPK-DN or Ad-GFP (MOI 5) was delivered 24 h before adip-
ogenic stimulation followed by γ-T3 (1 μM) stimulation for 7 days (Fig. 6). 
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2.8 Immunofluorescence 
hASCs were cultured on coverslips for immunofluorescence microscopy and 
stained as described previously [39]. Briefly, cells were fixed with 3.7% para-
formaldehyde in PBS for 20 min, and then the coverslips were blocked and 
permeabilized with 0.1% saponin, 10 mM glycine, and 1.25 mg/mL goat 
serum for 1 h. For immuno-fluorescent staining of LC3 (Fig. 5D), the cover 
slips were incubated with a 1:25 dilution of the LC3B antibody (Cell signal-
ing) overnight at 4°C, followed by incubation with a 1:300 dilution of rho-
damine red-conjugated goat antirabbit IgG (Jackson Immunoresearch) for 
1 h. Florescent images were captured using a digital inverted fluorescence 
EVOS microscope (AMG). 4′,6-diamidino-2-phenylindole (DAPI) staining (1 
μg/mL) was used for counter staining of the nucleus. Additionally, frag-
mented nuclei (due to chronic γ-T3 treatment) were also visualized by DAPI 
staining (Fig. 5E). 
2.9 Statistical analysis 
Results are presented as means ± SEM. The data were statistically analyzed 
using Student’s t-test or one-way ANOVA with Tukey’s multiple compari-
son test. All analyses were performed with GraphPad Prism 5 (Version 5.04). 
3 Results 
3.1 γ-T3 specifically inhibits the early stage of adipocyte 
differentiation 
It has been shown that γ-T3 induces apoptosis in malignant tumor cells but 
not in mitogenically quiescent cells [12]. However, it is unknown whether 
γ-T3 affects the cell viability of human mesenchymal stem cells. To address 
this question, increasing doses (0.1–10 μM) of α-, β-, γ-T3, and α-TP were 
incubated with either undifferentiated hASCs (Fig. 1A), or fully differenti-
ated human mature adipocytes (Fig. 1B) in comparison to vehicle control 
(DMSO). As we expected, TP and α-T3 had no significant cytotoxic effects 
compared to the control. In contrast, an exposure to a high dose of γ-T3 or 
δ-T3 reduced cell viability in both the hASC cultures (>1 _M) and in mature 
adipocytes (>5 μM) (Fig. 1). 
It has been shown that T3, but not TP, suppressed adipogenic differentia-
tion in 3T3L1 cells, a well-studied murine preadipocyte cell line [33]. To de-
termine whether T3 was able to inhibit adipogenesis in uncommitted cells, 
hASCs were induced to differentiate into adipocytes with either T3 isomers 
or TP for 10 days at different doses (0.1, 0.5, and 1 μM) compared to DMSO 
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(vehicle) control (Fig. 2A). Consistent with a previous report in 3T3L1 cells, 
only T3s-inhibited adipogenesis in hASCs; TP did not show any significant 
impact on TG accumulation and adipogenic gene expression (Supporting 
Information Fig. 1). The rank order of anti-adipogenic potential was γ-T3 > 
δ-T3 >> α-T3 as assessed by triglyceride accumulation using Oil-red O stain-
ing. Intriguingly, this anti-adipogenic effect was selective in the early stage 
of differentiation (d1–d4). When T3s were added on day 4, the anti-adipo-
genic effect of T3s was abolished (Fig. 2B). Similarly, when T3s were added 
to fully differentiated cells on day 10, γ-T3 and δ-T3 did not seem to im-
pose any anti-adipogenic or antilipogenic effects, showing no changes of 
adiposity or any signs of dedifferentiation (Fig. 2C). These results show that 
the anti-adipogenic effects of T3 in hASCs are isomer-specific and time-sen-
sitive, only effective in the early stage of adipogenesis. 
To further confirm the anti-adipogenic effects of T3s, the hASCs were first 
induced to differentiate with either T3 isomer or TP treatment, and then ad-
ipogenic gene expression levels were quantified by qPCR. The adipocyte 
marker gene expression was extremely reduced in cultures treated with T3, 
especially with γ-T3 and δ-T3, and to a lesser extent with α-T3 (anti-adip-
ogenic potency γ-T3 > δ-T3 >> α-T3); the master adipogenic transcription 
factors of C/EBP-α and PPAR-γ were dramatically reduced in cultures with 
γ-T3 and δ-T3, without any change occurring in the C/EBP-β expression level. 
Downstream target genes of PPAR-γ, including fatty acid binding protein 4 
(FABP4, also known as aP2), adiponectin, hormone-sensitive lipase, glucose 
transporter 4, and the lipid droplet-coating protein perilipin (PLIN), were all 
significantly reduced correspondingly. Notably, there was no significant in-
crease in the expression of inflammatory gene TNF-α; this supports that the 
inhibition of adipogenesis by γ-T3 was not accompanied by inflammation 
(Fig. 3A). We next profiled the expression of C/EBP genes during the first 48 
h of adipogenesis. γ-T3 treatment failed to trigger C/EBP-α at 48 h without 
any significant difference in C/EBP-δ and C/EBP-β profiles, suggesting that 
γ-T3 acts on upstream of C/EBP-α but downstream of C/EBP-β to control ad-
ipogenesis (Fig. 3B). In parallel, the extent to which γ-T3 and δ-T3 reduced 
the adipogenic protein expression levels of PPAR-γ, aP2, and fatty acid syn-
thase were equivalent to their attenuation in the adipogenic gene profile 
(Fig. 3C). Based on these results, we determined that a 1 μM dose of γ-T3 
was potent to inhibit new fat cell formation of hASCs. Thus, 1 μM γ-T3 was 
used for the remainder of the studies to further investigate the anti-adipo-
genic mechanism of γ-T3. 
3.2 γ-T3 alters Akt/mTOR/AMPK pathway 
It has been previously reported that γ-T3 attenuates adipogenesis in 3T3L1 
preadipocytes through Akt signaling modification [33]. To verify whether 
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the delayed insulin response is also the mechanism responsible for reduced 
adipogenesis in hASCs, we examined the basal- and insulin-stimulated re-
sponses. There was no significant difference in insulin-stimulated Akt and 
ERK phosphorylation (Fig. 4A). Although basal Akt phosphorylation seemed 
to be reduced (~30%) in γ-T3-treated cultures compared to control (Fig. 4C), 
the insulin responsive machinery seems to be intact in hASCs in the pres-
ence of γ-T3. 
Several phytochemicals are known to inhibit adipogenesis through the 
mechanism related to AMPK activation [29, 30, 38]. AMPK is regarded as 
a major energy-sensing regulator that activates a variety of catabolic pro-
cesses and simultaneously prevents anabolic processes via inhibition of the 
mTOR pathway [40]. To investigate whether γ-T3 is able to modify energy- 
and nutrient-sensing pathways, we examined AMPK and mTOR signaling. 
Treatment with γ-T3 decreased mTOR phosphorylation and its downstream 
target p70S6 kinase compared to TP treatment (Fig. 4B) or vehicle control 
(Fig. 4C). A decrease of mTOR and Akt phosphorylation was concurrent with 
an increase of AMPK phosphorylation (Fig. 4C), indicating that catabolic sig-
nals are upregulated with γ-T3 treatment. 
3.3 γ-T3 increases chronic autophagy and promotes apoptotic cell 
death 
Autophagy, a self-digestive process, is an essential signaling pathway for 
white adipocyte differentiation [41]. Autophagy is also a principal pathway 
that determines cell fate in response to stress by adjusting energy require-
ments such as starvation [42]; under glucose starvation, autophagy is pro-
moted by AMPK to generate nutrients and maintain energy homeostasis, 
while autophagy is inhibited by mTOR activation, a integrative growth sig-
nal [43–45]. Because we observed that γ-T3 alters nutrient sensing signals 
(a decrease of p-mTOR but an increase of p-AMPK, Fig. 4),we hypothesized 
that γ-T3 will promote autophagic degradation, which will be distinct from 
the constitutive autophagy for white fat cell differentiation. To address this 
question, we first investigated the dynamics of autophagy in hASCs during 
adipogenic differentiation. As we expected, insoluble autophagosome for-
mation (LC3II bands) increased robustly starting at the exit of the early dif-
ferentiation stage (d4); additionally, the levels remained higher after ter-
minal differentiation compared to undifferentiated hASCs. The increase of 
autophagy during adipocyte differentiation was parallel to (i) an increase 
of beclin 1 (Atg6), a critical component for nucleation of autophagic vesi-
cles; (ii) an degradation of p62/SQSTM1, an adapter protein that is selec-
tively degraded via autophagy; and (iii) an increase of adipogenic markers of 
PPAR-γ and aP2 (Fig. 5A). Furthermore, addition of chloroquine (CQ), an in-
hibitor of lysosomal degradation, increased LC3II accumulation, confirming 
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the augmented autophagy flux during adipogenic differentiation (data not 
shown). Interestingly, despite the reduced adipogenesis (low expression of 
aP2), γ-T3 treatment enhanced autophagosome formation (increase of in-
soluble LC3II) as well as p62 degradation (Fig. 5B). Noticeably, an increase 
of autophagy by γ-T3 was not coupled to an increase of beclin-1 (Fig. 5B), 
suggesting that γ-T3 treatment may trigger a beclin 1-independent autoph-
agic degradation in comparison to the obligatory autophagy for adipocyte 
differentiation seems to be beclin 1-dependent. An increase of autophagy 
flux by γ-T3 was also confirmed by immunostaining of LC3 in the presence 
of CQ as well as the adenoviral delivery of GFP-tagged LC3 (in the absence 
of CQ); accumulation of autophagosome (LC3II) in cytoplasm was increased 
in cultures with γ-T3 treatment compared to TP control (Fig. 5C). 
It has been shown that autophagy and apoptosis are intimately involved 
in deciding cell fate (survival versus cell death), and usually these two pro-
cesses are mutually exclusive of each other [46]. Hence, we next asked 
whether γ-T3 causes autophagic cell death instead of apoptotic cell death. 
After chronic exposure of γ-T3 for 10 days, cleaved PARP and caspase-3 pep-
tide were detectable by Western blot analysis, showing that cells are eventu-
ally undergoing caspase 3 dependent apoptotic cell death (Fig. 5D). Apop-
totic cell death was also confirmed in fragmented-nuclei by DAPI staining 
(Fig. 5E). The Bax/Bcl-2 ratio, a determinant for apoptosis, was dramatically 
increased (~20 fold) at day 10 (Fig. 5F). This increase was mostly due to a 
compromised Bcl-2 gene expression rather than an increase of Bax, impli-
cating that decreased Bcl-2 levels may be a metabolic switch from progres-
sive autophagy to apoptosis. Thus, these findings reveal that γ-T3 causes 
aberrant autophagy during adipocyte differentiation, which eventually in-
duces caspase 3-mediated cell death in hASCs. 
3.4 Inhibition of AMPK activation partially restores PPAR-γ expres-
sion but not autophagy activation 
To further determine whether inhibition of AMPK activation could reverse 
the anti-adipogenic effects of γ-T3, we used a dominant negative strategy 
by delivering a kinase-null mutant of AMPK (Ad AMPK-DN). hASCs were in-
fected with either Ad GFP or Ad AMPK-DN before adipogenic differentia-
tion. Then, cultures were induced to differentiate with TP or γ-T3 for 7 days. 
Adenoviral infection of Ad AMPK-DN was confirmed by an increase of total 
AMPK protein levels, with a decrease of phosphorylated AMPK protein lev-
els. Infection of Ad AMPK-DN caused a slight reduction of adipogenesis in 
basal levels. The blockage of AMPK activation rescued the PPAR-γ protein in 
γ-T3-treated cultures comparable to TP control (Fig. 6A). However, inhibition 
of AMPK activation was only partially effective in restoring lipid-loaded mor-
phology of adipocytes in γ-T3 treated cultures (Fig. 6B). Despite a significant 
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increase of PPAR-γ expression, mRNA levels of PLIN, a lipid droplet-coat-
ing protein of adipocytes, were not affected by AMPK inhibition (Fig. 6C). 
More intriguingly, inhibition of AMPK activation failed to dampen the γ-T3-
mediated autophagosome formation and p62 degradation (Fig. 6A). These 
data suggest that γ-T3-induced a unique autophagy pathway that is inde-
pendent to AMPK activation and plays a key role in opposing adipogenesis. 
4 Discussion 
The goal of this study was to investigate the effect of γ-T3 on new fat cell 
formation focusing on the signal modification during adipogenesis. We 
demonstrated definitively that γ-T3 specifically suppressed the early stage 
of adipogenesis and promoted apoptosis through pathways associated with 
AMPK and autophagy, with little impact on mature adipocytes (Fig. 4–6). To 
our knowledge, this study is the first report that γ-T3 induces AMPK and au-
tophagy activation reducing adipogenesis in primary hASCs, a physiologi-
cally more relevant adipocyte model to humans than 3T3L1 murine preadi-
pocytes. Collectively, our work here suggests that suppression of adipogenic 
conversion by γ-T3 may constitute a new dietary strategy to manage hy-
perplastic obesity. 
The seminal observation that γ-T3 plays an inhibitory role in adipogenesis 
was also provided by the 3T3L1 cell line [33]. In several aspects, our results 
from hASCs are compatible with those from 3T3L1 cells. In both studies, γ-T3 
and δ-T3 displayed stronger anti-adipogenic effects than α-T3, suggesting 
that the lack of a methyl group at position 5 (R1) of the chromanol ring may 
contribute to the inhibitory activity. The inhibitory activity may be due to 
generation of a bioactive metabolite of T3 by ω-oxidation [47], although it 
has not yet been identified. In addition, the active dose range to inhibit ad-
ipogenesis was similar in the two adipocyte models. γ-T3 inhibits approxi-
mately 80–90% of adipogenic gene expression in 3T3L1 cells at 0.024 ~2.4 
μM [33]. Similarly, our data also showed that ~90% suppression of adipo-
genesis was achieved by treatment with 1 μM γ-T3 (Fig. 2, 3). Importantly, 
anti-adipogenic activity is limited to early-phase adipogenesis without af-
fecting pre-existing adipocytes in both murine [33] and human adipocyte 
progenitor cells (Fig. 2C). Based on results from two different cell models of 
adipocytes, it is indicative that an adequate dose of γ-T3 for inhibition of 
adipogenesis is physiologically attainable by oral supplementation without 
causing dedifferentiation of mature adipocytes. One of the distinct metabolic 
differences between 3T3L1 cells and hASCs with γ-T3 treatment arises from 
the insulin response. Uto-Kondo et al. concluded that the anti-adipogenic 
response of γ-T3 in 3T3L1 cells is due to the decreased-Akt phosphoryla-
tion upon insulin stimulation [33], which was not the case in hASCs (Fig. 4A). 
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Our next signaling focus was AMPK and autophagy. Adipocyte differen-
tiation is an anabolic process that is sensed by “nutritionally affluent” sig-
nals strictly coupled to energy storage demands. AMPK is regarded as a ma-
jor energy-sensing regulator that activates a variety of catabolic processes 
and simultaneously prevents anabolic processes via inhibition of the mTOR 
pathway [48]. Although the direct roles of nutrient-sensing signaling in ad-
ipogenesis are not fully understood, it appears that adipogenesis is highly 
susceptible to the changes in the cellular energy status. Broad ranges of 
phytochemicals have been reported to suppress adipogenesis through the 
AMPK pathway in vitro and in vivo [29, 30, 38, 49, 50]. As we expected, an 
inverse relationship between the AMPK and mTOR pathways was observed 
in hASCs, confirming a global growth-inhibitory action of γ-T3 during adi-
pogenesis (Fig. 4B, C). In parallel to previous reports that AICAR, a pharma-
cological agonist of AMPK, almost completely blocks adipogenesis of 3T3L1 
cells [49], we also found that AICAR was also effective in inhibiting adipo-
genesis in hASCs (data not shown). The upstream mechanism by which γ-T3 
induces AMPK activation is likely dependent on intracellular calcium activa-
tion. Our unpublished data showed that γ-T3 triggers upregulation of in-
tracellular calcium levels (data not shown). Further studies for identification 
of upstream targets of AMPK activation will reveal the upstream signaling 
partners that synergistically act to antagonize adipogenesis. The underlying 
mechanism by which γ-T3 activates AMPK is currently being investigated to 
elucidate mechanistic details. 
Autophagy is a lysosomal degradation pathway that degrades damaged 
or superfluous cell components for stress adaptation or survival [51–53]. Al-
though there are remaining questions about whether adipogenesis is cou-
pled to mitochondria-specific autophagy (mitophagy) or not, recent work 
has established that autophagy is required to fulfill the white adipocyte de-
velopment in vivo and in vitro [26, 27]. In our study, we have demonstrated 
that autophagic degradation concurrently occurred at the same time as tran-
scriptional activation of PPAR-γ in hASCs (Fig. 5A, B). Surprisingly, we have 
demonstrated that γ-T3 increased autophagy even further than the normal 
adipogenic process. In addition, γ-T3- mediated autophagosomes seem to 
have a different composition based on decreased levels of beclin1 (Fig. 5C). 
Due to the limited knowledge of adipocyte autophagy and technical diffi-
culties in distinguishing autophagic pathways (i.e. macroautophagy, mitoph-
agy, and lipophagy), it is difficult to understand the precise molecular nature 
of γ-T3-mediated autophagy. Further studies are required to determine the 
physiological importance of γ-T3-mediated autophagy during adipogenesis 
by comparing autophagosome components. However, we assume that γ-T3-
mediated autophagy is a process that is associated with subsequent Bcl-2/
caspase 3 mediated apoptosis (Fig. 5D–F). Our results indicate that autoph-
agy is a critical signaling checkpoint for determining whether mesenchymal 
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stem cells differentiate into adipocytes or undergo the alternative cell-death 
pathway based on the micro-environmental setting. 
It has been documented that the mTOR/AMPK /autophagy axis is coor-
dinately regulated by fuel availability via the molecular mediator Ulk1 phos-
phorylation in glucose-depleted situation [52, 54]. It did not seem to apply 
to the γ-T3 treatment in hASCs: We failed to detect Ulk1 phosphorylation 
(Ser 317, data not shown); the blockage of AMPK activation was unable to 
inhibit γ-T3-mediated autophagy (Fig. 6A).Moreover, the rescue of PPAR-γ 
without normalization of autophagy was not effective in complete resto-
ration of adipocyte morphology (Fig. 6B, C). Defective adipocyte morphol-
ogy may be a result of, at least in part, low levels of PLIN that protects lipid 
droplets from cytosolic lipases. It has not been investigated whether γ-T3-
induced autophagosome is engulfing lipids (lipophagy) or specific coact-
ivators for PPAR-γ. Further research on understanding the molecular na-
ture of γ-T3-induced autophagy is underway. Taken together, our data also 
lead us to conclude that γ-T3-mediated AMPK and autophagy activation 
are two independent mechanisms that synergistically inhibit the adipogen-
esis of hASCs. 
In conclusion, our study demonstrated that γ-T3 efficiently suppresses 
early adipogenic processes in hASC through growth inhibitory signaling 
pathways including AMPK and autophagy activation. Although additional 
studies are required to determine the exact molecular nature, our study has 
provided a novel insight into an anti-adipogenic role of AMPK and autoph-
agy activation by γ-T3.    
Figure 1. Effects of tocotrienols (T3) on cell viability in hASCs. Cultures of hASCs containing 
either undifferentiated (A) or differentiated (B) cells were treated with 0.1–10 μM tocopherol 
(TP, ○) or α-(Δ), δ-(●), and γ-(■) T3 for 24 h. XTT reagent was added 3 h before measurement 
of OD450. Data are expressed as a percentage of the vehicle control (DMSO). Each data point 
represents the mean ± SEM (n = 6). * p < 0.05 ; ** p < 0.01 ; *** p < 0.001 by one-way ANOVA. 
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Figure 2. γ-, δ-T3s selectively suppress early-phase adipogenesis but not terminal differenti-
ation. hASCs were seeded at the day before differentiation (d0) and induced to differentiate 
the next day (d1*). TP, α-, δ-, and γ-T3s, or DMSO (vehicle control) were added at different 
phases of adipogenesis (shown in arrow). The effects of TP and T3 on early-stage adipogen-
esis (0.1–1 μM) (A), late-stage adipogenesis (1 μM) (B), or fully differentiated adipocytes (5 
μM) (C) were examined. Red bars indicate the duration of T3 isomer treatment. Triglycer-
ide accumulation was visualized by Oil red-O staining and representative images from three 
separate experiments are shown. Extracted staining was quantified (OD500 nm) and relative 
TG accumulation to the DMSO control was graphed in A. *** p < 0.001 by one-way ANOVA. 
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Figure 3. γ-, δ-T3s repress adipogenic gene and protein expression in hASCs. Cultures of hASCs were induced 
to differentiate in the presence of either 1 μM TP or α-, δ-, or γ-T3 for 10 days. (A) qPCR analysis for adipo-
genic gene expression of C/EBP-β, C/EBP-α, PPAR-γ, aP2, adiponectin, PLIN, glucose transporter 4, hormone-
sensitive lipase, and TNF-α normalized by the average of two reference genes (36B4 and GAPDH), (B) Effects 
of γ-T3 (1 μM) on the dynamics of the adipogenic transcription factors C/EBP-δ, C/EBP-β, and C/EBP-α during 
early adipogenesis (0, 6, 12, 24, and 48 h). (C) Total cell extracts were immunoblotted for adipogenic protein 
expression of PPAR-γ, aP2, FAS. β-actin was used as a loading control. In A, data are expressed as the mean ± 
SEM from n = 4 samples of two separate experiments. Means not sharing a common superscript differ by one-
way ANOVA (p < 0.05). In B, duplicate samples were pooled for qPCR analysis.  
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Figure 4. γ-T3 modulates nutrient-sensing pathways of the Akt/mTOR/AMPK axis. Cultures 
of hASCs were differentiated for 6 days in the presence or absence (DMSO only) of γ-T3. (A) 
Cultures were stimulated with (+) or without (−) human insulin (100 nM) for 10 min. Total cell 
extracts were immunoblotted for phospho-specific or total antibodies targeting protein ki-
nase B (Akt, ERK). (B) Cultures were treated with 1 μM TP, or γ-T3 for 3 h in serum-free me-
dia. Fetal bovine serum stimulation (20%) for 30 min was used as a positive control for mTOR 
activation. After treatment, total cell extracts were immunoblotted for total and phospho-
specific mTOR and p70 S6 ribosomal protein kinase (p70S6K). (C) Cultures were treated for 3 
h with (+) or without (−, DMSO only) 1 μM γ-T3. Total cell extracts were immunoblotted us-
ing phosphospecific or total antibodies for Akt, mTOR, and AMPK.  
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Figure 5. γ-T3 promotes autophagy. (A) Increase of beclin-1, autophagosome formation 
(LC3II), and p62 degradation during adipogenic differentiation in hASCs. PPAR-γ, and aP2 
were also shown as evidence for differentiation. (B) Western blot analysis of beclin-1, LC3, 
p62, and aP2 expression with or without γ-T3 for 7 days in differentiating hASCs. (C) Immu-
nostaining of LC3 in the presence and absence of γ-T3. CQ was added at the last 4 h before 
fixing the cells (upper panel). Autophagosome formation by γ-T3 was also confirmed by ad-
enoviral infection of GFP-tagged Ad LC3 (lower panel). (D) Western blot analysis of cleaved-
PARP and cleaved-caspase3. (E) Cultures grown in the presence or absence (DMSO only) of 
γ-T3 for 10 days were fixed and the nuclei were stained with DAPI. Arrows indicate condensed 
or fragmented nuclei. (F) The relative ratio of Bax and Bcl-2 gene expression at 10 days of ad-
ipogenic differentiation was obtained by qPCR. Representative images from three separate 
experiments with duplicated samples are shown in A and B. ***p < 0.001 by Student’s t-test. 
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Figure 6. Inhibition of AMPK activation partially reverses the anti-adipogenic effects of γ-T3 
in hASCs. (A) Western blot analysis of phosphor-specific and total AMPK, PPAR-γ, and LC3 
expression in the presence or absence of 1 μM γ-T3 treatment in Ad GFP or Ad AMPK-DN 
(Ad expressing DN AMPK) infected hASCs. (B) Adenoviral overexpression of DN AMPK par-
tially rescues adipocyte morphology. Phase-contrast images after 7 days of differentiation 
with either TP or γ-T3 in Ad GFP and Ad-AMPK-DN infected cultures. Results are represen-
tative of two independent experiments with triplicated samples. (C) PPAR-γ and PLIN mRNA 
expression in the presence or absence of 1 μM γ-T3 treatment in Ad GFP or Ad-AMPK-DN 
infected hASCs. Results are normalized to Ad GFP infected cells, and are expressed as mean 
± SEM of triplicate analyses. Values not sharing a common letter differ significantly by one-
way ANOVA with Tukey’s multiple comparison.    
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Supporting Information 
Supplement Table 1. Primer sequences for qPCR 
Gene Forward/Reverse Sequence (5′-3’) 
C/EBP 
Forward AGTTCTTGGGACATAGGAGCGCA 
Reverse GTACCTTAGCTGCATCAACAGGAG 
C/EBP 
Forward CGTGTGTACACGGGACTGAC 
Reverse CAACAAGCCCGTAGGAACAT 
C/EBP 
Forward CCACGCCTGTCCTTAGAAAG 
Reverse CCCTCCACCTTCATGTAGAAC 
PPAR 
Forward GAGCCCAAGTTTGAGTTTGC 
Reverse CTGTGAGGACTCAGGGTGGT 
aP2 
Forward ACTGGGCCAGGAATTTGACGAAGT 
Reverse TCTCGTGGAAGTGACGCCTTTCAT 
Adiponectin 
Forward TTGAGGCTGGGCCATCTCCT 
Reverse AGCTCCCAGCAACAGCATCC 
Perilipin 
Forward ACATTAAAGGGAAGAAGTTGAAGC 
Reverse TTCTCCTGCTCAGGGAGGT 
GLUT4 
Forward GCTACCTCTACATCATCCAGAATCTC 
Reverse CCAGAAACATCGGCCCA 
HSL 
Forward CTCAGTGTGCTCTCCAAGTG 
Reverse CACCCAGGCGGAAGTCTC 
TNF 
Forward GGCAGTCAGATCATCTTCTCG 
Reverse GGTTTGCTACAACATGGGCTA 
Bax 
Forward TGGAGCTGCAGAGGATGATTG 
Reverse GAAGTTGCCGTCAGAAAACATG 
Bcl-2 
Forward TTGCTTTACGTGGCCTGTTTC 
Reverse GAAGACCCTGAAGGACAGCCAT 
GAPDH 
Forward GGCCTCCAAGGAGTAAGACC 
Reverse AGGGGAGATTCAGTGTGGTG 
36B4 
Forward GAAGGCTGTGGTGCTGATG 
Reverse GTGAGGTCCTCCTTGGTGAA 
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